logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

SNOA
Sonoma Pharmaceuticals, Inc.
1.21
2 x 0.88
3 x 1.84
bid
ask
-
0.02
1.63%
3 @ 05:55 AM
1.18 -0.03 (2.46%)
Ytd-66.76%
1y-58.98%
1.20
day range
1.23
0.85
52 week range
6.92
Open1.21Prev Close1.23Low1.20High1.23Mkt Cap5.79M
Vol59.56KAvg Vol237.62KEPS-1.89P/EN/AForward P/E-1.49
Beta1.38Short Ratio0.22Inst. Own2.42%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1150-d Avg1.19200-d Avg2.771yr Est19.50

SNOA News

benzinga.com
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance For Its Microdacyn Wound Irrigation Solution

Clearance includes expanded claims, clearance for multiple use, and additional packaging configurati

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
accessnewswire.com
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for

BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global

benzinga.com
Sonoma Pharmaceuticals Q4 EPS $(0.33) Misses $(0.24) Estimate, Sales $5.561M Miss $5.565M Estimate

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.33) per share which missed the